Sanara MedTech Inc. Cash Flow Statement
SMTI|13 years of annual SEC 10-K data (FY2012-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
Sanara MedTech Inc. used $23,784 in operating cash flow and negative free cash flow of $229,632 in FY2025.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$9.7M | -$4.3M | -$7.9M | -$7.9M | -$4.4M | -$2.8M | $331.3K | -$415.7K | -$1.3M | -$2.3M | -$4.1M | -$1.8M | -$12.7M |
| Depreciation & Amortization | $4.9M | $3.7M | $2.4M | $597.0K | $291.4K | $120.0K | $80.6K | $60.9K | $60.0K | $56.4K | $51.7K | $61.2K | $470.6K |
| Operating Cash Flow | -$23.8K | -$3.2M | -$5.6M | -$4.8M | -$4.0M | -$2.2M | -$139.9K | $409.2K | -$1.2M | -$1.7M | -$1.8M | -$1.2M | -$343.6K |
| Capital Expenditures | $205.8K | $265.2K | $147.0K | $171.9K | $544.4K | $182.8K | $43.9K | $3.0K | $5.3K | $8.1K | $29.9K | $29.9K | - |
| Free Cash Flow | -$229.6K | -$3.5M | -$5.7M | -$5.0M | -$4.6M | -$2.4M | -$183.8K | $406.2K | -$1.2M | -$1.7M | -$1.9M | -$1.3M | - |
| Share Buybacks | - | - | - | - | - | $1.1K | - | - | - | - | - | - | - |
| FCF Margin | -0.3% | -5.4% | -12.4% | -20.6% | -29.4% | -20.0% | -2.9% | 7.4% | -35.8% | -64.4% | -107.3% | -107.0% | - |